Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Invariant human TCR Valpha24-Jalpha18+/Vbeta11+ NKT cells (iNKT) are restricted by CD1d-alpha-glycosylceramides. We analyzed crystal structures and binding characteristics for an iNKT TCR plus two CD1d-alpha-GalCer-specific Vbeta11+ TCRs that use different TCR Valpha chains. The results were similar to those previously reported for MHC-peptide-specific TCRs, illustrating the versatility of the TCR platform. Docking TCR and CD1d-alpha-GalCer structures provided plausible insights into their interaction. The model supports a diagonal orientation of TCR on CD1d and suggests that complementarity determining region (CDR)3alpha, CDR3beta, and CDR1beta interact with ligands presented by CD1d, whereas CDR2beta binds to the CD1d alpha1 helix. This docking provides an explanation for the dominant usage of Vbeta11 and Vbeta8.2 chains by human and mouse iNKT cells, respectively, for recognition of CD1d-alpha-GalCer.

Original publication

DOI

10.1084/jem.20052369

Type

Journal article

Journal

J Exp Med

Publication Date

20/03/2006

Volume

203

Pages

699 - 710

Keywords

Animals, Antigen Presentation, Antigens, CD1, Antigens, CD1d, Complementarity Determining Regions, Crystallography, X-Ray, Galactosylceramides, Humans, Killer Cells, Natural, Mice, Models, Molecular, Protein Binding, Protein Structure, Quaternary, Receptors, Antigen, T-Cell, alpha-beta, Structure-Activity Relationship, T-Lymphocytes